APG Asset Management N.V. Sells 29,600 Shares of Colgate-Palmolive Company $CL

APG Asset Management N.V. trimmed its position in shares of Colgate-Palmolive Company (NYSE:CL) by 2.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,207,622 shares of the company’s stock after selling 29,600 shares during the period. APG Asset Management N.V.’s holdings in Colgate-Palmolive were worth $96,537,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. ProShare Advisors LLC lifted its position in shares of Colgate-Palmolive by 11.0% during the 3rd quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock worth $163,681,000 after buying an additional 202,379 shares during the last quarter. Providence Capital Advisors LLC acquired a new position in Colgate-Palmolive during the third quarter worth about $5,373,000. Asset Management One Co. Ltd. lifted its holdings in shares of Colgate-Palmolive by 3.9% in the third quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after acquiring an additional 16,017 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Colgate-Palmolive by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock valued at $7,522,129,000 after purchasing an additional 993,432 shares in the last quarter. Finally, TD Waterhouse Canada Inc. boosted its stake in shares of Colgate-Palmolive by 248.5% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock valued at $6,909,000 after purchasing an additional 62,327 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 20th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. UBS Group increased their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Citigroup boosted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Finally, Wells Fargo & Company upped their target price on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Stock Performance

NYSE CL opened at $99.01 on Friday. The company has a market capitalization of $79.81 billion, a price-to-earnings ratio of 37.79, a PEG ratio of 4.47 and a beta of 0.29. The company has a quick ratio of 0.27, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The stock has a fifty day simple moving average of $87.49 and a 200 day simple moving average of $82.72.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.1%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Insider Activity

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 184,683 shares of company stock worth $17,486,693 over the last quarter. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.